Noile-Immune Biotech (TSE:4893) EPS (Basic) : 円-22.62 (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech EPS (Basic)?

Noile-Immune Biotech's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was 円-7.86. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was 円-22.62.

Noile-Immune Biotech's EPS (Diluted) for the three months ended in Mar. 2024 was 円-7.86. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was 円-23.25.

Noile-Immune Biotech's EPS without NRI for the three months ended in Mar. 2024 was 円-7.86. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was -23.25.

During the past 3 years, the average EPS without NRI Growth Rate was -24.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Noile-Immune Biotech's highest 3-Year average EPS without NRI Growth Rate was -24.60% per year. The lowest was -24.60% per year. And the median was -24.60% per year.

Noile-Immune Biotech EPS (Basic) Historical Data

The historical data trend for Noile-Immune Biotech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech EPS (Basic) Chart

Noile-Immune Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

-15.48

-19.34

-9.87

-27.25

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial				-12.49	-8.54	0.22	-6.44	-7.86

Noile-Immune Biotech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Noile-Immune Biotech's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1130.014	-	0)	/	41.468
	=	-27.25

Noile-Immune Biotech's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-340.177	-	0)	/	43.285
	=	-7.86

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-22.62

Noile-Immune Biotech (TSE:4893) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Noile-Immune Biotech EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech (TSE:4893) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012

Website

https://www.noile-immune.com

Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines